本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

66.00
+0.77501.19%
成交量:9.76万
成交额:645.59万
市值:62.21亿
市盈率:-138.51
高:66.90
开:65.74
低:65.74
收:65.22
52周最高:66.90
52周最低:17.05
股本:9,426.11万
流通股本:9,276.71万
量比:0.59
换手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
净资产收益率:-236.35%
总资产收益率:-3.73%
市净率:253.68
市盈率(LYR):-230.47

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/09

重要事件披露

Form 8-K - Current report
2026/06/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities